PCRX
Pacira BioSciences Inc.
Company Overview
| Mkt Cap | $1.23B | Price | $21.38 |
| Volume | 831.24K | Change | +0.52% |
| P/E Ratio | -12.4 | Open | $21.27 |
| Revenue | $304.0K | Prev Close | $21.27 |
| Net Income | $-99.6M | 52W Range | $16.00 - $27.64 |
| Div Yield | N/A | Target | $29.00 |
| Overall | 53 | Value | 60 |
| Quality | 55 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyPacira BioSciences Inc. (PCRX) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $21.38 with a market capitalization of $1.23 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 55.
Today's trading session shows PCRX with a volume of 831K shares. The stock opened down 0.00% from yesterday's close of $21.27. Current analyst estimates project earnings of $1.95 per share for this year, with next year targeting $2.24.
PCRX demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including DRRX, REPH, HRTX, BDSI, ACUR.
Key investment considerations for PCRX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 35.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:13 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PCRX | $21.38 | +0.5% | 831.24K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |